CridMD, Nigeria’s leading innovation driven e-health startup has acquired retail pharmaceutical company Charisland Pharmaceuticals (CP) as part of efforts aimed at expanding its market share in the space and ensure drug delivery straight to patients’ homes across Nigeria.
CribMD, which was launched in June 2020 to connect users with doctors for house calls and telemedicine services via its on-demand platform, allowing them to schedule appointments from the comfort and safety of their home, on their own schedule has witnessed remarkable growth in the last one year.
It has built an active subscriber base of more than 3,000, and to spur quicker expansion has now used some of the US$2.6 million in seed funding it raised earlier this year to acquire CP. Incorporated in 2009, CP is exiting the Nigerian market and relocating to Canada, so the deal was mutually beneficial.
Read also:South African Health-tech Startup, iNNOHEALTH, Secures Seven-figure Seed Funding
Speaking on the acquisition, Ifeanyi Ossai, chief executive officer (CEO) and co-founder of CribMD said that the startup’s values with the pharmaceutical firm overlap, and it’s our overall vision for the healthcare space is similar.
“CribMD’s product offerings are shaping out well. We already have telemedicine and doctor house visits running smoothly. Our recent acquisition will further solidify the online pharmacy offering. We hope to add more in the coming months.”
Read also:Nigeria’s Terragon Verified as Leader in Data and Marketing Technology
Kelechi Deca
Kelechi Deca has over two decades of media experience, he has traveled to over 77 countries reporting on multilateral development institutions, international business, trade, travels, culture, and diplomacy. He is also a petrol head with in-depth knowledge of automobiles and the auto industry